High Expression of lncRNA HEIH is Helpful in the Diagnosis of Non-Small Cell Lung Cancer and Predicts Poor Prognosis

References

• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424. doi:10.3322/caac.21492
   PubMed Web of Science ®Google Scholar
• Hirsch FR, Scagliotti GV, Mulshine JL, et al. Lung cancer: current therapies and new targeted treatments. Lancet. 2017;389:299–311. doi:10.1016/S0140-6736(16)30958-8
   PubMed Web of Science ®Google Scholar
• Ettinger DS, Wood DE, Aggarwal C, et al. NCCN guidelines insights: non-small cell lung cancer, version 1.2020. J Natl Compr Canc Netw. 2019;17:1464–1472. doi:10.6004/jnccn.2019.0059
   PubMed Web of Science ®Google Scholar
• Zhang J, Zhu N, Chen X. A novel long noncoding RNA LINC01133 is upregulated in lung squamous cell cancer and predicts survival. Tumour Biol. 2015;36:7465–7471. doi:10.1007/s13277-015-3460-9
   PubMedGoogle Scholar
• Kim L, Kim KH, Yoon YH, et al. Clinicopathologic and molecular characteristics of lung adenocarcinoma arising in young patients. J Korean Med Sci. 2012;27:1027–1036. doi:10.3346/jkms.2012.27.9.1027
   PubMed Web of Science ®Google Scholar
• Zhao S, Guo X, Mizutani KI, et al. Overexpression of teashirt homolog 2 suppresses cell proliferation and predicts the favorable survival of lung adenocarcinoma. Int J Med Sci. 2021;18:1980–1989. doi:10.7150/ijms.52109
   PubMed Web of Science ®Google Scholar
• Saito S, Espinoza-Mercado F, Liu H, Sata N, Cui X, Soukiasian HJ. Current status of research and treatment for non-small cell lung cancer in never-smoking females. Cancer Biol Ther. 2017;18:359–368. doi:10.1080/15384047.2017.1323580
   PubMed Web of Science ®Google Scholar
• Yang Y, Wang M, Liu B. Exploring and comparing of the gene expression and methylation differences between lung adenocarcinoma and squamous cell carcinoma. J Cell Physiol. 2019;234:4454–4459. doi:10.1002/jcp.27240
   PubMed Web of Science ®Google Scholar
• Fu L, Wang H, Wei D, et al. The value of CEP55 gene as a diagnostic biomarker and independent prognostic factor in LUAD and LUSC. PLoS One. 2020;15:e0233283. doi:10.1371/journal.pone.0233283
   PubMed Web of Science ®Google Scholar
• Souza CP, Cinegaglia NC, Felix TF, et al. Deregulated microRNAs are associated with patient survival and predicted to target genes that modulate lung cancer signaling pathways. Cancers. 2020;12:2711. doi:10.3390/cancers12092711
   PubMed Web of Science ®Google Scholar
• Beylerli OA, Azizova ST, Konovalov NA, Akhmedov AD, Gareev IF, Belogurov AA. [Non-coding RNAs as therapeutic targets in spinal cord injury]. Zh Vopr Neirokhir Im N N Burdenko. 2020;84:104–110. Russian. doi:10.17116/neiro202084031104
   PubMedGoogle Scholar
• Lorenzi L, Avila Cobos F, Decock A, et al. Long noncoding RNA expression profiling in cancer: challenges and opportunities. Genes Chromosomes Cancer. 2019;58:191–199. doi:10.1002/gcc.22709
   PubMed Web of Science ®Google Scholar
• Jiao PF, Tang PJ, Chu D, Li YM, Xu WH, Ren GF. Long non-coding RNA THOR depletion inhibits human non-small cell lung cancer cell growth. Front Oncol. 2021;11:756148. doi:10.3389/fonc.2021.756148
   PubMed Web of Science ®Google Scholar
• Wang T, Yang C, Li B, et al. Identification of lncRNA-miRNA-mRNA networks linked to non-small lung cancer resistance to inhibitors of epidermal growth factor receptor. Front Genet. 2021;12:758591. doi:10.3389/fgene.2021.758591
   PubMed Web of Science ®Google Scholar
• Song H, Li H, Ding X, et al. Long noncoding RNA FEZF1AS1 facilitates nonsmall cell lung cancer progression via the ITGA11/miR516b5p axis. Int J Oncol. 2020;57:1333–1347. doi:10.3892/ijo.2020.5142
   PubMed Web of Science ®Google Scholar
• Yang J, Qiu Q, Qian X, et al. Long noncoding RNA LCAT1 functions as a ceRNA to regulate RAC1 function by sponging miR-4715-5p in lung cancer. Mol Cancer. 2019;18:171. doi:10.1186/s12943-019-1107-y
   PubMed Web of Science ®Google Scholar
• Shi X, Liu Z, Liu Z, et al. Long noncoding RNA PCAT6 functions as an oncogene by binding to EZH2 and suppressing LATS2 in non-small-cell lung cancer. EBioMedicine. 2018;37:177–187. doi:10.1016/j.ebiom.2018.10.004
   PubMed Web of Science ®Google Scholar
• Reis EM, Verjovski-Almeida S. Perspectives of long non-coding RNAs in cancer diagnostics. Front Genet. 2012;3:32. doi:10.3389/fgene.2012.00032
   PubMedGoogle Scholar
• Luo J, Li Q, Pan J, Li L, Fang L, Zhang Y. Expression level of long noncoding RNA H19 in plasma of patients with nonsmall cell lung cancer and its clinical significance. J Cancer Res Ther. 2018;14:860–863. doi:10.4103/jcrt.JCRT_733_17
   PubMed Web of Science ®Google Scholar
• Tan J, Yang L. Long noncoding RNA VPS9D1-AS1 overexpression predicts a poor prognosis in non-small cell lung cancer. Biomed Pharmacother. 2018;106:1600–1606. doi:10.1016/j.biopha.2018.07.113
   PubMed Web of Science ®Google Scholar
• Xie Y, Zhang Y, Du L, et al. Circulating long noncoding RNA act as potential novel biomarkers for diagnosis and prognosis of non-small cell lung cancer. Mol Oncol. 2018;12:648–658. doi:10.1002/1878-0261.12188
   PubMed Web of Science ®Google Scholar
• Yang F, Zhang L, Huo XS, et al. Long noncoding RNA high expression in hepatocellular carcinoma facilitates tumor growth through enhancer of zeste homolog 2 in humans. Hepatology. 2011;54:1679–1689. doi:10.1002/hep.24563
   PubMed Web of Science ®Google Scholar
• Cui C, Zhai D, Cai L, Duan Q, Xie L, Yu J. Long noncoding RNA HEIH promotes colorectal cancer tumorigenesis via counteracting miR-939Mediated transcriptional repression of Bcl-xL. Cancer Res Treat. 2018;50:992–1008. doi:10.4143/crt.2017.226
   PubMed Web of Science ®Google Scholar
• Jia K, Chen F, Xu L. Long noncoding RNA HEIH promotes the proliferation and metastasis of non-small cell lung cancer. J Cell Biochem. 2019;120:3529–3538. doi:10.1002/jcb.27629
   PubMed Web of Science ®Google Scholar
• Zhao H, Xing G, Wang Y, Luo Z, Liu G, Meng H. Long noncoding RNA HEIH promotes melanoma cell proliferation, migration and invasion via inhibition of miR-200b/a/429. Biosci Rep. 2017;37. doi:10.1042/BSR20170682
   Web of Science ®Google Scholar
• Beasley MB, Brambilla E, Travis WD. The 2004 World Health Organization classification of lung tumors. Semin Roentgenol. 2005;40:90–97. doi:10.1053/j.ro.2005.01.001
   PubMed Web of Science ®Google Scholar
• Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc. 2008;3:1101–1108. doi:10.1038/nprot.2008.73
   PubMed Web of Science ®Google Scholar
• Clevers MR, Kastelijn EA, Peters BJM, Kelder H, Schramel F. Evaluation of serum biomarker CEA and Ca-125 as immunotherapy response predictors in metastatic non-small cell lung cancer. Anticancer Res. 2021;41:869–876. doi:10.21873/anticanres.14839
   PubMed Web of Science ®Google Scholar
• Dal Bello MG, Filiberti RA, Alama A, et al. The role of CEA, CYFRA21-1 and NSE in monitoring tumor response to Nivolumab in advanced non-small cell lung cancer (NSCLC) patients. J Transl Med. 2019;17:74. doi:10.1186/s12967-019-1828-0
   PubMed Web of Science ®Google Scholar
• Li C, Lv Y, Shao C, et al. Tumor-derived exosomal lncRNA GAS5 as a biomarker for early-stage non-small-cell lung cancer diagnosis. J Cell Physiol. 2019;234:20721–20727. doi:10.1002/jcp.28678
   PubMed Web of Science ®Google Scholar
• Li Q, Sang S. Diagnostic value and clinical significance of combined detection of serum markers CYFRA21-1, SCC Ag, NSE, CEA and ProGRP in non-small cell lung carcinoma. Clin Lab. 2020;66. doi:10.7754/Clin.Lab.2020.191243
   Web of Science ®Google Scholar
• Zamarron E, Prats E, Tejero E, et al. Static lung hyperinflation is an independent risk factor for lung cancer in patients with chronic obstructive pulmonary disease. Lung Cancer. 2019;128:40–46. doi:10.1016/j.lungcan.2018.12.012
   PubMed Web of Science ®Google Scholar
• Wang M, Dai M, Wang D, et al. The long noncoding RNA AATBC promotes breast cancer migration and invasion by interacting with YBX1 and activating the YAP1/Hippo signaling pathway. Cancer Lett. 2021;512:60–72.
   PubMed Web of Science ®Google Scholar
• He Y, Jiang X, Duan L, et al. LncRNA PKMYT1AR promotes cancer stem cell maintenance in non-small cell lung cancer via activating Wnt signaling pathway. Mol Cancer. 2021;20:156. doi:10.1186/s12943-021-01469-6
   PubMed Web of Science ®Google Scholar
• Zhang C, Gong C, Li J, Tang J. Downregulation of long non-coding RNA LINC-PINT serves as a diagnostic and prognostic biomarker in patients with non-small cell lung cancer. Oncol Lett. 2021;21:210. doi:10.3892/ol.2021.12471
   PubMed Web of Science ®Google Scholar
• Liu Y, Liang L, Ji L, et al. Potentiated lung adenocarcinoma (LUAD) cell growth, migration and invasion by lncRNA DARS-AS1 via miR-188-5p/ KLF12 axis. Aging. 2021;13:23376–23392. doi:10.18632/aging.203632
   PubMedGoogle Scholar
• Sun Y, Hu B, Wang Q, et al. Long non-coding RNA HOTTIP promotes BCL-2 expression and induces chemoresistance in small cell lung cancer by sponging miR-216a. Cell Death Dis. 2018;9:85. doi:10.1038/s41419-017-0113-5
   PubMed Web of Science ®Google Scholar
• Zhang YL, Li XB, Hou YX, Fang NZ, You JC, Zhou QH. The lncRNA XIST exhibits oncogenic properties via regulation of miR-449a and Bcl-2 in human non-small cell lung cancer. Acta Pharmacol Sin. 2017;38:371–381. doi:10.1038/aps.2016.133
   PubMed Web of Science ®Google Scholar
• Jiang P, Hao S, Xie L, et al. LncRNA NEAT1 contributes to the acquisition of a tumor like-phenotype induced by PM 2.5 in lung bronchial epithelial cells via HIF-1alpha activation. Environ Sci Pollut Res Int. 2021;28:43382–43393. doi:10.1007/s11356-021-13735-7
   PubMed Web of Science ®Google Scholar
• Iacuzzo C, Germani P, Troian M, et al. Serum carcinoembryonic antigen pre-operative level in colorectal cancer: revisiting risk stratification. ANZ J Surg. 2021;91:E367–E374.
   PubMed Web of Science ®Google Scholar
• Zhang M, Huang C, Zhou H, et al. Circulating tumor DNA predicts the outcome of chemotherapy in patients with lung cancer. Thorac Cancer. 2021;13:95–106.
   PubMed Web of Science ®Google Scholar
• Jiao Z, Cao S, Li J, et al. Clinical associations of preoperative and postoperative serum CEA and lung cancer outcome. Front Mol Biosci. 2021;8:686313. doi:10.3389/fmolb.2021.686313
   PubMed Web of Science ®Google Scholar
• Pezzuto A, Spoto C, Vincenzi B, Tonini G. Short-term effectiveness of smoking-cessation treatment on respiratory function and CEA level. J Comp Eff Res. 2013;2:335–343. doi:10.2217/cer.13.25
   PubMed Web of Science ®Google Scholar
• Yaghoubi N, Avval FZ, Khazaei M, Sahebkar A, Aghaee-Bakhtiari SH. High diagnostic and prognostic value of miRNAs compared with the carcinoembryonic antigen as a traditional tumor marker. Anticancer Agents Med Chem. 2021. doi:10.2174/1871520621666210608094908
   Web of Science ®Google Scholar
• Chen X, Sun X, Li X, Xu L, Yu W. LncRNA-HEIH is a novel diagnostic and predictive biomarker in gastric cancer. Genet Test Mol Biomarkers. 2021;25:284–292. doi:10.1089/gtmb.2020.0270
   PubMed Web of Science ®Google Scholar
• Si L, Chen J, Yang S, et al. lncRNA HEIH accelerates cell proliferation and inhibits cell senescence by targeting miR-3619-5p/CTTNBP2 axis in ovarian cancer. Menopause. 2020;27:1302–1314. doi:10.1097/GME.0000000000001655
   PubMed Web of Science ®Google Scholar
• Ding X, Qi C, Min J, Xu Z, Huang K, Tang H. Long non-coding RNA HEIH suppresses the expression of TP53 through enhancer of zeste homolog 2 in oesophageal squamous cell carcinoma. J Cell Mol Med. 2020;24:10551–10559. doi:10.1111/jcmm.15673
   PubMed Web of Science ®Google Scholar